Great idea and very convenient, but too many botched deliveries.
Review: One star.
That, in a nutshell, sums up investors’ sentiments on Yelp (YELP) right now. The company’s stock fell as much as 30% in after hours trading Tuesday after the company posted disappointing sales results.
That drop effectively erases all Yelp’s stock gains from the last year.
Yelp reported sales of $197.3 million for the first quarter, falling short of Wall Street estimates. Its guidance for the upcoming quarter and full year also fell short of analyst estimates.
On a conference call with analysts, Yelp’s top execs blamed the sales miss on a struggle to hold on to local advertising accounts that had signed up a year earlier.
Jeremy Stoppelman, Yelp’s CEO, said there were “emerging businesses that had trouble competing in the ad system” and jumped ship. Yelp noticed greater churn “halfway through the quarter,” according to Stoppelman.
“It was all hands on deck at that point,” he added. “We put a team in place to focus on that particular cohort.”
low risk investments: ADDvantage Technologies Group, Inc.(AEY)
- [By Jim Robertson]
Today, our Under the Radar Moversnewsletter suggestedshorting small cap cable television and telecommunications equipment stock ADDvantage Technologies Group, Inc (NASDAQ: AEY):
low risk investments: Radient Technologies (RTI)
- [By Jim Robertson]
Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:
- [By Bryan Murphy]
It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.
Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.
Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.
To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.
With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.
It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.
Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.
Using its patented MAP process, Radient is able to selectiv
- [By Matthew Briar]
At first glance, a new set of rules from the Drug Enforcement Agency unveiled in the middle of December looked like it posed a problem for cannabis-newcomer Radient Technologies Inc (CVE:RTI). By assigning a controlled substances code number to ‘marijuana extract,’ simultaneously distinguishing (and acknowledging the differences of marijuana, hemp and their derivatives as Schedule I substances. As the ruling’s language explained, “This code number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana. This, in turn, will aid in complying with relevant treaty provisions.”
It presents something of an uncertainty, as it was not clear of the DEA also meant hemp and cannabis extracts when it used the term ‘marijuana extract.’ After all, the Drug Enforcement Agency has thus far done a poor job of distinguishing between hemp and marijuana, but has generally erred on the side of grouping everything as marijuana…. even if it didn’t cause a ‘high,’ and even if it did provide a medical benefit. If that was indeed the case, Radient Technologies may well be a non-starter in its quest to get into the cannabis business.
No need to worry. Though it took weeks to get some much-needed clarification, the DEA has finally explained what it was saying two months ago. Indeed, the new ruling may actually help the medical marijuana — cannabis — along. DEA spokesman Russ Baer said in an e-mail to The Cannabist, “(The rule change) recognizes that there is a potential medical benefit to some of the cannabinoids.”
Some still worry the wording of the law essentially, even if unintentionally, puts cannabinoids (or CBD) under the purveyance of the DEA; it’s currently not. Even so, if nothing else the ruling has the government moving towards clarity, after acknowledging CBD — the healthy version of the cannabis, and not the one that gets you high — has medical value. The next step is clarifying ho
- [By Jim Robertson]
Shares of small cap natural compound and Cannabinoid extract stock Radient Technologies (CVE: RTI) have been taking off lately as the Company makes further progress commercializing its technology. The Company extracts natural compounds from a range of biological materials using microwave assisted processing (MAP), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield and cost. This technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source. This gives the Company a technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass’ complicated chemical system form the core of our extraction advantage.
- [By Matthew Briar]
Although the past several years have been very good ones for the cannabis — marijuana and hemp — industry, it’s still mostly being done in an old, artisan-style fashion. Most companies haven’t figured out a way of scaling up their outputs by improving their operating/production efficiency, even though the market’s growth has merited. Radient Technologies Inc (CVE:RTI) represents that next evolution of the cannabinoid business, introducing a new approach to extracting cannabinoids from cannabis plants that will not only improve yields, but create a superior, purer product.
Canada-based Radient Technologies has developed — and patented – an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along. To fully appreciate why it matters, however, one has look at the approach other ingredients suppliers are utilizing now.
With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated to 50 degrees Celsius (or more), and over the course of several hours, the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.
It works, but it’s hardly ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, a lot of things you don’t want to extract can still be found in the extract, lowering the quality and purity of the ingredient.
Radient Technologies’ microwave assisted processing changes all of this.
Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which
low risk investments: Chipotle Mexican Grill Inc.(CMG)
- [By Dan Caplinger, Tim Brugger, and Seth McNew]
Risk is always a factor for stock market investors, but if you want the top stocks in your portfolio, you have to be bold. To give you some ideas on which stocks to look at, three Motley Fool contributors weighed in on companies they’re familiar with and made a case for why they deserve a closer look. Read on to learn more about Shopify (NYSE:SHOP), Chipotle Mexican Grill (NYSE:CMG), and Universal Display (NASDAQ:OLED) and why they deserve your attention.
- [By WWW.THESTREET.COM]
Chipotle Mexican Grill (CMG) : “This is not on my to do list right now.”
On Real Money, Cramer looks at which retailers are doing better — and better yet, which offer investment opportunities. Get his insights with a free trial subscription to Real Money.
- [By Casey Wilson]
Unfortunately, there were a lot of disappointing companies to choose from. We picked the worst of the worst. Check out our list of the most-hated companies of 2016…
Most-Hated Companies 2016 No. 5: Chipotle Mexican Grill Inc. (NYSE: CMG)
Chipotle’s problems all started in July 2015 with an E. coli outbreak…
low risk investments: Church & Dwight Company, Inc.(CHD)
- [By Wayne Duggan]
U.S. retailers performed poorly during the Christmas holiday season, but companies in the Valentine’s Day business are hoping that Americans will spend generously in the name of love this year. These names include flower delivery company 1-800-Flowers.Com Inc (NASDAQ: FLWS), L Brands Inc (NYSE: LB) (owner of both Victoria’s Secret and Bath & Body Works), Church & Dwight Co., Inc. (NYSE: CHD) (owner of Trojan brand condoms), candy giant Hershey Co (NYSE: HSY) and luxury jeweler Tiffany & Co. (NYSE: TIF).
- [By Monica Gerson]
Church & Dwight Co., Inc. (NYSE: CHD) shares rose 7.32 percent to $104.10 in pre-market trading. Negocios.com reported that Reckitt Benckiser will offer $23 billion for Church & Dwight.
- [By Shauna O’Brien]
Deutsche Bank announced on Tuesday that it has upgraded Church & Dwight Co., Inc. (CHD).
The firm has raised its rating on CHD from “Hold” to “Buy,” and has increased the company’s price target from $64 to $66. This price target suggests an 8% upside from the stock’s current price of $60.36.
Analyst Bill Schmitz commented: “Sustainable growth algorithm of 3-4% organic sales, high single digit EBIT and double-digit EPS growth intact, with upside from fast growing Avid vitamin business joining the base and highly flexible balance sheet enabling further M&A or more aggressive cash flow redeployment providing upside to total shareholder return profile.
“With shares underperforming the group and market over the last year and tempered Street outlook for CY14 versus long-term trend, we see an opportunistic window to own the shares at a reasonable entry point.”
Church & Dwight shares were mostly flat during pre-market trading Tuesday. The stock is up 13% YTD.
- [By Ben Levisohn]
Remember when companies used to split their stock to keep individual shares affordable? No longer. Credit Suisse strategistsAna Avramovic andVictor Lin note that Church & Dwight (CHD) upcoming stock split will be just the fourth by an S&P 500 stock this year:
low risk investments: SPAR Group Inc.(SGRP)
- [By Jim Robertson]
On Wednesday, our Under the Radar Moversnewsletter suggested going long on small cap international merchandising and marketing services stockSPAR Group Inc (NASDAQ: SGRP):